↓ Skip to main content

Oncotarget

Creation of a new class of radiosensitizers for glioblastoma based on the mibefradil pharmacophore

Overview of attention for article published in Oncotarget, April 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news
5 news outlets
twitter
12 X users
facebook
1 Facebook page
reddit
1 Redditor
video
1 YouTube creator

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
9 Mendeley
Title
Creation of a new class of radiosensitizers for glioblastoma based on the mibefradil pharmacophore
Published in
Oncotarget, April 2021
DOI 10.18632/oncotarget.27933
Pubmed ID
Authors

Sateja Paradkar, James Herrington, Adam Hendricson, Piyasena Hewawasam, Mark Plummer, Denton Hoyer, Ranjini K. Sundaram, Yulia V. Surovtseva, Ranjit S. Bindra

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 22%
Researcher 2 22%
Other 1 11%
Student > Master 1 11%
Unknown 3 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 44%
Pharmacology, Toxicology and Pharmaceutical Science 2 22%
Unknown 3 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 47. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 May 2021.
All research outputs
#797,981
of 23,650,645 outputs
Outputs from Oncotarget
#294
of 14,083 outputs
Outputs of similar age
#22,735
of 438,530 outputs
Outputs of similar age from Oncotarget
#14
of 66 outputs
Altmetric has tracked 23,650,645 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 14,083 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,530 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 66 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.